What it does / how it works
Longer GHRH analogue plus a GH pulse from ipamorelin. Tesamorelin is the labelled visceral-fat GHRH. The blend ratio may deliver more ipamorelin than a solo 250 mcg pulse.
| Class | Blend · T110 5+5 mg · T116 13+3 mg · T130 20+10 mg |
| Typical vial | Stock vial, not one dose |
| Reconstitution | T110: 2 mL BAC = 2.5 mg/mL of each. |
| Storage after mix | 2–8°C, use within 28 days |
Protocol
| Goal | Dose | How often | How long | Route |
| T110 start | Tesamorelin 1 mg + Ipa 1
mg (0.40 mL) |
Once daily evening | 8-12 weeks | SubQ |
| T110 standard | Tesamorelin 2 mg + Ipa 2
mg (0.80 mL) |
Once daily evening | 8-26 weeks | SubQ |
| If Ipa must stay 200-300 mcg | Use separate vials: Tesamorelin 2 mg + Ipa 250 mcg |
Once daily evening |
8-26 weeks |
SubQ |
Watch: T130 is 20+10 mg. Never inject the vial. Watch IGF-1.